Capricor Therapeutics CAPR
NASDAQ CAPR
$8.94 -0.53 (-5.60%)
At close: Oct 1, 2026 · 4:00 PM EDT

Capricor Therapeutics (CAPR) Return on Equity [ROE] (2011 - 2026)

Updated

Capricor Therapeutics' Return on Equity [ROE] came in at -48.15% for Q2 2026, up 11.92 percentage points from -60.07% a year earlier but down 9.98 percentage points from the prior quarter.

Analysis

Capricor Therapeutics (CAPR) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

For FY2025, Capricor Therapeutics' Return on Equity [ROE] was -46.56%, up 1.60 percentage points from FY2024.

  • Return on Equity [ROE] has increased in each of the last three years, with a five-year change of +31.40 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Equity [ROE] was -48.16% in FY2024 (+81.83 pp), -129.98% in FY2023 (+5.23 pp), -135.22% in FY2022 (-65.11 pp) and -70.11% in FY2021 (+7.84 pp).
  • The five-year range for quarterly Return on Equity [ROE] is -6191.10% (Q3 2023) to -37.77% (Q4 2024).
  • Year-over-year, Return on Equity [ROE] increased in six of the last eight quarters, with an average year-over-year change of +810.79 percentage points.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2024 (a gain of 6105.40 percentage points), and the weakest in Q3 2023 (a drop of 6028.00 percentage points).
  • Business Quant data shows CAPR's Return on Equity [ROE] at -38.17% (Q1 2026), -52.36% (Q4 2025) and -86.72% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Capricor Therapeutics 550.29 Mn 550.29 Mn - -48.15%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -48.15%
Mar 31, 2026 -38.17%
Dec 31, 2025 -52.36%
Sep 30, 2025 -86.72%
Jun 30, 2025 -60.07%
Mar 31, 2025 -40.25%
Dec 31, 2024 -37.77%
Sep 30, 2024 -85.70%
Jun 30, 2024 -187.11%
Mar 31, 2024 -118.80%
Dec 31, 2023 -214.75%
Sep 30, 2023 -6,191.10%
Jun 30, 2023 -653.27%
Mar 31, 2023 -323.76%
Dec 31, 2022 -214.43%
Sep 30, 2022 -163.09%
Jun 30, 2022 -118.88%
Mar 31, 2022 -84.08%
Dec 31, 2021 -61.32%
Sep 30, 2021 -53.33%
API Access

Capricor Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CAPR&period=max&api_key=YOUR_API_KEY